<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791735</url>
  </required_header>
  <id_info>
    <org_study_id>APHP180681</org_study_id>
    <nct_id>NCT04791735</nct_id>
  </id_info>
  <brief_title>Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma</brief_title>
  <acronym>LapCHC</acronym>
  <official_title>Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatocellular carcinoma treated by laparotomy or laparoscopic Multicenter prospective, open,&#xD;
      superiority, controlled, randomized, clinical trial The primary objective of the study will&#xD;
      be to demonstrate the superiority of the laparoscopic approach over the open approach in&#xD;
      reducing postoperative morbidity in HCC patients.&#xD;
&#xD;
      Postoperative morbidity will be assessed using the Comprehensive Complication Index (CCI)&#xD;
      within 90 days postoperatively or at any time during hospitalization&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2021</start_date>
  <completion_date type="Anticipated">May 2026</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>the intervention group is Laparoscopic approach for liver resection of HCC The standard arm is the open approach for liver resection of HCC. Both this standard arm and the laparoscopic arm are in the realm of usual care.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective of the study will be to demonstrate the superiority of the laparoscopic approach over the open approach in reducing postoperative morbidity in HCC patients.</measure>
    <time_frame>90 days after inclusion</time_frame>
    <description>Postoperative morbidity will be assessed using the Comprehensive Complication Index (CCI) within 90 days postoperatively or at any time during hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of postoperative complications (grade at least 1 according to the Dindo-Clavien classification) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of postoperative complications (grade at least 3 according to the Dindo-Clavien classification) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality (grade 5 according to the Dindo-Clavien classification or a CCI of 100) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of specific liver related complications (ascites, liver failure, biliary fistula, hemorrhage) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of organ space and superficial surgical site infection (SSI) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of abdominal wall complications (abscess, hematoma) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of postoperative pulmonary complications (pleural effusion, respiratory insufficiency, acute respiratory distress syndrome, pulmonary embolism) within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of unplanned reoperation within 90 days postoperatively or at any time during hospitalization.</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain evaluated with a visual analogic scale on postoperative D0, D1, D2, D3, D5, D7 and discharge.</measure>
    <time_frame>day of surgery, 1, 2, 3, 5 and 7 days after surgery</time_frame>
    <description>EVA is visual analogic scale 0 to 10, graduation of 1 0 is no pain ans 10 is maximum pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay and occurrence of unplanned readmission after discharge within 90 days postoperatively</measure>
    <time_frame>90 days after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Quality Recovery Scale (PQRS) on postoperative D7, D30 and D90</measure>
    <time_frame>1, 3, 5, 7, 30, 60, 90 days after inclusion</time_frame>
    <description>PQRS = Postoperative Suality Recovery Scane self-questionary Min = 20 and Max = 120</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean surgical margin widths (in millimeters).</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of microscopically complete (R0), microscoically incomplete (R1) and macroscopically incomplete (R2) resections as stated in the pathological report.</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients recurring within 2 years following liver resection.</measure>
    <time_frame>inclusion</time_frame>
    <description>This cut-off value is widely accepted for differentiating recurrence of the resected lesion (&lt; 2 years postoperatively) from de novo lesion occurring on a background diseased liver parenchyma (&gt; 2 years).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall and disease free survivals.</measure>
    <time_frame>60 month</time_frame>
    <description>percentage of hepatocellular carcinoma recurrence percentage of deaths at end of follow-up</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>Laparoscopic approach for liver resection of HCC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>laparotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopy</intervention_name>
    <description>Installations of the patient: the position of the patient will depend on both extent of resection and location of the lesion.&#xD;
Absence of laparotomy with the exception of the extraction of the resected specimen and absence of costal retractors.&#xD;
Use of laparoscopic specific devices:&#xD;
Use of multiple (3-7) ports depending on the operator's preference and technical difficulty (mainly 5-6 ports for major liver resection).&#xD;
Use of a laparoscopic camera system with 0° or 30°&#xD;
Use of a dedicated laparoscopic ultrasound probe.&#xD;
Use of specific laparoscopic devices for coagulation, parenchymal transection and sealing.&#xD;
Placement of the resected specimen in a plastic bag and extraction without fragmentation, depending on the surgeon's preferenceand the diameter of the resected specimen</description>
    <arm_group_label>Laparoscopic approach for liver resection of HCC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparotomy</intervention_name>
    <description>Installation of the patient: patients will be placed in supine position, the surgeon operating on the right side of the patient and the assistant standing on the left side.&#xD;
Incision: the type of incision will depend on both the nature of the resection and the operator's preference. Various incisions such as bi subcostal incision, J-shaped incision, right subcostal incision and midline incision can be used.&#xD;
Use of open surgical instruments and devices for coagulation and parenchymal transection. These may include the crush-clamp technique or ultrasonic dissection for parenchymal transection, bipolar coagulation, clips, sutures or open vascular stapler for hemostasis and biliostasis.&#xD;
Methylene blue injection through the cystic drain to rule out biliary leakage will be performed depending on the surgeon's preference.</description>
    <arm_group_label>laparotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female patient aged ≥ 18 years&#xD;
&#xD;
          -  Presenting with solitary or multifocal resectable HCC&#xD;
&#xD;
          -  Qualifying for both pure laparoscopic and open approaches&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Physical or psychological status contraindicating the participation to the study&#xD;
&#xD;
          -  Contraindication to surgery&#xD;
&#xD;
          -  Contraindication to pneumoperitoneum&#xD;
&#xD;
          -  ASA (American Society of Anesthesiologists) score IV-V&#xD;
&#xD;
          -  Life expectancy &lt; 2 months&#xD;
&#xD;
          -  Suspicion of mixed type tumor (Hepatocholangiocarcinoma) and fibrolamellar HCC&#xD;
&#xD;
          -  Child-Pugh score &gt; B7&#xD;
&#xD;
          -  Extra-hepatic involvement&#xD;
&#xD;
          -  Liver resection requiring an associated vascular or biliary reconstruction&#xD;
&#xD;
          -  Pregnancy and breast-feeding&#xD;
&#xD;
          -  Tutorship, trusteeship&#xD;
&#xD;
          -  Concurrent participation in other experimental trials concerning the same objective&#xD;
             within 90 days following intervention&#xD;
&#xD;
          -  No Affiliation to the French social security&#xD;
&#xD;
          -  No Ability to give their consent and not written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chirurgie Digestive - CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>REGIMBEAU Jean Marc</last_name>
      <phone>03 22 08 88 90</phone>
      <email>regimbeau.jean-marc@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgie viscérale et digestive - CHU Caean</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LUBRANO Jean Marc</last_name>
      <email>lubrano-j@chu-caen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgie Hépatologie - Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CAUCHY Francois</last_name>
      <phone>06 46 53 58 75</phone>
      <email>francois.cauchy@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgie Digestive et Hépatobiliaire - Hôpital Henri-Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chirurgie Diestive et de l'Urgence - CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chirurgie Digestive et Transplantations - Hôpital Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chirurgie Générale, Digestive et de la Transplantation hépatique - Hôpital de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chirurgie Digestive - CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>HERRERO Astrid</last_name>
      <email>a-herrero@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgie digestive - Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cochin hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FUKS David</last_name>
      <phone>01 58 41 50 09</phone>
      <email>david.fuks@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgie hépato-biliaire et greffe de foie - La Pitié</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SCATTON Olivier</last_name>
      <phone>01 84 82 74 27</phone>
      <email>olivier.scatton@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chirurgie viscérale et digestive - CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chirurgie hépato-bilio-pancréatique et Transplantation - Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chirurgie digestive Oncologique Endocrinienne et Transplantation hépatique - CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BUCUR Petru</last_name>
      <phone>06 29 42 13 64</phone>
      <email>bucur.petru@chu-tours.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hépatobiliaire de transplantation hépatique - Hopital Paul Brousse</name>
      <address>
        <city>Villejuif</city>
        <zip>94800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laparoscopy</keyword>
  <keyword>laparotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

